The association of intraprostatic calcifications and dosimetry parameters with biochemical control after permanent prostate implant
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Brachytherapy
- Vol. 18 (6) , 787-792
Abstract
No abstract availableKeywords
Funding Information
- Canadian Cancer Society Research Institute
This publication has 14 references indexed in Scilit:
- Prevalence of Prostatic Calcification Subtypes and Association With Prostate CancerUrology, 2015
- Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: Implications for focal salvage brachytherapyRadiotherapy and Oncology, 2013
- Report of the Task Group 186 on model‐based dose calculation methods in brachytherapy beyond the TG‐43 formalism: Current status and recommendations for clinical implementationMedical Physics, 2012
- ABS brachytherapy consensus guidelinesBrachytherapy, 2012
- Sci-Sat AM(2): Brachy - 05: Fast Monte Carlo Dose Calculations for Brachytherapy with BrachyDoseMedical Physics, 2010
- Calcifications in prostate and ejaculatory system: a study on 298 consecutive whole mount sections of prostate from radical prostatectomy or cystoprostatectomy specimensAnnals of Diagnostic Pathology, 2008
- Benchmarking BrachyDose: Voxel based EGSnrc Monte Carlo calculations of TG‐43 dosimetry parametersMedical Physics, 2007
- Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculationsMedical Physics, 2004
- Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine‐125 interstitial implantsMedical Physics, 1998
- Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43Medical Physics, 1995